Outlook Therapeutics Inc (NASDAQ:OTLK)
| 1.39 Delayed Data As of Aug 14 |  +0.05 / +3.73%Today’s Change | 0.50 Today|||52-Week Range 2.14 | +135.59% Year-to-Date |
Latest OTLK News | Press Releases
| Outlook Therapeutics EPS beats by $0.07 Aug 14 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 1.34 |
| Today’s open | 1.33 |
| Day’s range | 1.33 - 1.49 |
| Volume | 110,195 |
| Average volume (3 months) | 2,422,584 |
| Market cap | $160.1M |
Data as of 3:59pm ET, 08/14/2020
Growth & Valuation
| Earnings growth (last year) | +79.65% |
| Earnings growth (this year) | +48.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +163.84% |
| P/E ratio | NM |
| Price/Sales | 3.33 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| JNCEJounce Therapeutics ... | -0.15 | -3.11% |
| PIRSPieris Pharmaceutica... | -0.07 | -2.25% |
| EQEquillium Inc | -1.57 | -17.80% |
| NCNANuCana PLC | +0.15 | +2.85% |
Data as of 4:53pm ET, 08/14/2020
Financials
| Last reporting date | August 14, 2020 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $8.1M |
| Annual profit (last year) | -$34.6M |
| Net profit margin | -424.56% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South Brunswick, New Jersey |
Forecasts
